Dr. Hurvitz is director, Breast Cancer Clinical Research Programs at the Geffen School of Medicine at UCLA and an assistant professor of medicine, Division of Hematology/Oncology, David Geffen School of Medicine at UCLA. She is also the co-director of the Santa Monica-UCLA Outpatient Hematology/Oncology Practice and medical director of the Jonsson Comprehensive Cancer Center Clinical Research Unit. Dr. Hurvitz is interested in designing and implementing phase I and II (translational) breast cancer clinical trials. Dr. Hurvitz is also interested in studying the gene expression patterns in a variety of breast cancer populations and evaluating these patterns to detect new subtypes of breast cancer that may be more accurately targeted by novel therapies.
